Brief: Geneuro End-Dec Net Cash Position At 6.8 Million Euros

Geneuro SA

11/01/2021 07:24

Jan 11 (Reuters) - GENEURO SA  GNRO.PA :
    * AT DECEMBER 31, 2020, GENEURO HAD NO DEBT
    * GENEURO: CASH POSITION AT DECEMBER 31, 2020, BUSINESS
UPDATE AND
OUTLOOK FOR 2021
    * NET CASH POSITION OF EUR 6.8 MILLION AT DECEMBER 31, 2020
WITH
FINANCIAL VISIBILITY TO Q2 2022
    * PHASE 2 CLINICAL TRIAL OF TEMELIMAB IN MULTIPLE SCLEROSIS
(MS)
WITH KAROLINSKA INSTITUTET / ACADEMIC SPECIALIST CENTER OF
STOCKHOLM: RECRUITMENT EXPECTED TO BE COMPLETED IN FEB 2021
    * PHASE 2 CLINICAL TRIAL OF TEMELIMAB IN MULTIPLE SCLEROSIS
(MS)
WITH KAROLINSKA INSTITUTET / ACADEMIC SPECIALIST CENTER OF
STOCKHOLM TOP LINE RESULTS NOW EXPECTED FOR Q1 2022
    * COMPANY'S PRECLINICAL DEVELOPMENT PROGRAM FOR ITS PHERV-K
ENV
ANTIBODY IN THIS INDICATION AIMS TO INITIATE CLINICAL TRIALS IN
2022 AFTER COVID-RELATED DELAYS

Source text for Eikon:  ID:nACT66895 
Further company coverage:  GNRO.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))